MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/jir.s517789

Медицинская библиотека · Journal of inflammation research · 2025

Rbms3 Upregulation in Mesenchymal Stem Cells Impairs Fracture Healing in Type 2 Diabetes Mellitus.

Liu Changjiang, Yu Yifeng, Tian Liang, Liu Yuting, Zhang Dong, Yu Aixi

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Fracture healing can be delayed or impaired in individuals with abnormal conditions, including Type 2 Diabetes Mellitus (T2DM). Mesenchymal stem cells (MSCs) are critical to the process of fracture healing and are found to be impaired in T2DM. Although some research has been conducted to address this, the specific mechanisms remain poorly understood and warrant further exploration.

METHODS

We downloaded transcriptomic and single-cell RNA sequencing (scRNA-seq) data, performed multiple analyses (differential expression, ssGSEA, co-expression, GO, KEGG, GSEA, and cell clustering identification), and utilized tools (GeneMINIA and Metascape) to investigate alterations in MSCs under diabetic condition. Further validation and exploration were carried out through in vitro experiments (cell transduction, flow cytometry, ALP staining, ARS, qPCR, and Western blotting) and in vivo experiments (micro-CT, histological staining, and immunohistochemistry).

RESULTS

Our study identified differentially expressed genes from fracture healing and non-union cases in human samples, suggesting abnormal immune infiltration and disrupted biological processes. ScRNA-seq analysis further revealed significant alterations in MSCs under diabetic conditions with enriched pathways, including MAPK, TGF-β, and P53 signaling pathways. Integrating with transcriptomic analysis, we identified Rbms3, which was significantly upregulated in diabetic MSCs and further validated in bone samples from patients at our institution. The upregulation of Rbms3 impaired fracture healing by modulating the MAPK signaling pathway, leading to reduced MSC osteogenic differentiation in vitro and impaired bone regeneration in vivo.

CONCLUSION

The upregulation of Rbms3 in MSCs under diabetic conditions contributes to impaired fracture healing by modulating the MAPK signaling pathway.

Для цитирования: Liu Changjiang, Yu Yifeng, Tian Liang, Liu Yuting, Zhang Dong, Yu Aixi. Rbms3 Upregulation in Mesenchymal Stem Cells Impairs Fracture Healing in Type 2 Diabetes Mellitus.. Journal of inflammation research. 2025. DOI: 10.2147/jir.s517789.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.